Back
Microsoft Vs. Kymera Therapeutics Industry Stock Comparison
Buy
62
MSFT
Microsoft
Last Price:
$503.15
Seasonality Move:
2.98%
Buy
56
KYMR
Kymera Therapeutics
Last Price:
$44.49
Seasonality Move:
5.78%
Buy
56
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $44.48. The Score for KYMR is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $44.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
MSFT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 111.61 | Buy |
Relative Strength Index (14 RSI): | 71.71 | Buy |
Chaikin Money Flow: | 8679065 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (475.21 - 498.13) | Buy |
Bollinger Bands (100): | (382.2 - 471.6) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.93 | Buy |
Relative Strength Index (14 RSI): | 55.13 | Buy |
Chaikin Money Flow: | -27977 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.46 - 47.42) | Sell |
Bollinger Bands (100): | (27.32 - 42.48) | Buy |
MSFT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 498.08 | Buy |
20-day SMA: | 490.62 | Buy |
50-day SMA: | 467.24 | Buy |
200-day SMA: | 426.08 | Buy |
8-day EMA: | 318.14 | Buy |
20-day EMA: | 165.43 | Buy |
50-day EMA: | 74.13 | Buy |
200-day EMA: | 19.65 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.48 | Sell |
20-day SMA: | 45.45 | Sell |
50-day SMA: | 39.14 | Buy |
200-day SMA: | 39.49 | Buy |
8-day EMA: | 28.31 | Buy |
20-day EMA: | 14.72 | Buy |
50-day EMA: | 6.59 | Buy |
200-day EMA: | 1.75 | Buy |
Microsoft Earnings Growth & MSFT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.60 per share, an increase next quarter of $0.06 per share, an increase this year of $1.57 per share, and an increase next year of $1.73 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.20 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.41 per share.
Microsoft Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |